Drug recall · March 9, 2016
Thyrogen recall
Why: Presence of Particulate Matter: Glass particles found in the product after reconstitution.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Thyrogen (thyrotropin alfa for injection), 0.9 mg/mL after reconstitution, For intramuscular injection only, Rx Only, Two vials per Carton, Carton contains 2 vials of Thyrogen, Dilute with Sterile Water for Injection, Storage: store at 2-8 C, Manufactured by: Genzyme Corporation, Northborough, MA 01532 USA, Marketing Authorization holder: Sanofi-Aventis, NDC 58468-0030-2.
- Lots / codes
Lot #s: E4029Y03, E4029Y04, E4029Y06, E4029Y07, Exp 12/2017
- Quantity
- 4669 Cartons
- Company
- Genzyme Corporation, Cambridge, MA
- Distribution
- Nationwide, Puerto Rico and Malaysia, Taiwan, Brazil, and Israel.
- Initiated
- February 16, 2016 · Voluntary: Firm initiated
- Classified
- February 26, 2016
- Reported
- March 9, 2016
- Ended
- March 2, 2017
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.